AHSG and metabolic dysfunction-associated steatotic liver disease: Numerous studies have demonstrated a significant increase in serum fetuin-A levels in patients with nonalcoholic fatty liver disease (NAFLD), which is associated with insulin resistance and an elevated risk of future diabetes compared with controls [44, 45].